2017 US Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

March 2017 | 241 pages | ID: U3C0F1432AAEN
Venture Planning Group

Abstracts

Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag , and ALT/SGPT tests performed in the following markets:

• Hospitals
• Commercial/Private Labs
• Blood Banks
• Physician Offices
• Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 241 pages and 14 tables

Contents

I. INTRODUCTION

II. Hepatitis WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
  CLASSIFICATION
  TRANSMISSION OF INFECTION
  OCCUPATIONAL HAZARDS
  ACUTE HEPATITIS
  DIAGNOSIS OF ACUTE INFECTION
  CHRONIC HEPATITIS
  HCV AND OTHER CHRONIC LIVER DISEASES
  ALCOHOLIC LIVER DISEASE
  HEPATITIS B COINFECTION
  CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
  DIAGNOSTIC TESTS
  POSSIBLE INDICATIONS FOR HCV RNA TESTING
  CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
  HISTORICAL PERSPECTIVE
  EPIDEMIOLOGY
  HBVHDV 'COINFECTION' VS. 'SUPERINFECTION'
  METHODS OF DETECTING HDV
  PREVENTION
F. Hepatitis E
  BACKGROUND
  PREVALENCE OF THE DISEASE
  DIAGNOSTIC TESTS
  EPIDEMIOLOGIC SEROSURVEYS
  SEROLOGIC CROSSREACTIVITY
G. Hepatitis G
  VACCINES AND DRUGS
H. Review of Leading Analyzers Marketed by: Abbott, Beckman
Coulter/Danaher, BioMerieux, OrthoClinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
  1. MOLECULAR DIAGNOSTICS
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. DIFFERENTIAL LIGHT SCATTERING
  5. INFORMATION TECHNOLOGY
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. DIAGNOSTIC IMAGING
  11. GEL MICRODROPLETS
  12. OTHER

III. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized TESTING MARKETS
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Hepatitis Tests
U.S.A HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. AntiHBc Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. AntiHBs Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. AntiHAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier